Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative shivering
IRCT20211009052704N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine in postanesthetic shivering (PAS) (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Occurrence of postoperative shivering and Severity of postoperative shivering. Started Oct 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20211009052704N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211009052704N1.